PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Couturaud, Francis
TI  - Benefit of Extended Anticoagulation After Unprovoked PE Lost After Treatment Discontinuation
DP  - 2014  01
TA  - MD Conference Express
PG  - 11--11
VI  - 14
IP  - 55
4099  - http://mdc.sagepub.com/content/14/55/11.short
4100  - http://mdc.sagepub.com/content/14/55/11.full
AB  - After a first episode of unprovoked pulmonary embolism initially treated during 6 months, extending anticoagulant therapy with warfarin for an additional 18 months significantly reduces the risk of recurrent venous thromboembolism. However, by 2 years after therapy is discontinued, the risk of recurrent thrombolic events is no different between the warfarin treatment group and the placebo group.